HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease.

Abstract
We investigated whether the val(158)met functional polymorphism of catechol-o-methyltransferase influenced age-related changes in grey matter density and volume, both in healthy individuals (n=80, ages 18-79) and those with Parkinson's disease (n=50). Global grey matter volumes and voxelwise estimates of grey matter volume and density were determined from structural magnetic resonance images at 3T. Male and female ValVal homozygotes (low prefrontal cortical dopamine) had more grey matter in early adulthood, but this difference disappeared with increasing age. The insula and ventral prefrontal cortex had higher grey matter volume in younger, but not older, ValVal homozygotes. Conversely, the dominant premotor cortex revealed genotypic differences in grey matter density in later life. There were no global or local interactions between Parkinson's disease and COMT val(158)met genotype on morphometry. Since the val(158)met polymorphism is associated with differences in cortical dopamine metabolism, our data suggest a role for dopamine in cortical development followed by differential vulnerability to cortical atrophy across the adult life span.
AuthorsJ B Rowe, L Hughes, C H Williams-Gray, S Bishop, S Fallon, R A Barker, A M Owen
JournalNeurobiology of aging (Neurobiol Aging) Vol. 31 Issue 6 Pg. 1064-8 (Jun 2010) ISSN: 1558-1497 [Electronic] United States
PMID18755526 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2008 Elsevier Inc. All rights reserved.
Chemical References
  • Methionine
  • Catechol O-Methyltransferase
  • Valine
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aging (genetics)
  • Atrophy (genetics)
  • Catechol O-Methyltransferase (genetics)
  • Female
  • Genotype
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Male
  • Methionine (genetics)
  • Middle Aged
  • Parkinson Disease (genetics)
  • Polymorphism, Genetic (genetics)
  • Prefrontal Cortex (pathology)
  • Regression Analysis
  • Valine (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: